Clinical trial
MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
NCT02673021
Study timeline
Study start (actual)2016-06-08Date precision: day
Registry last updated2023-10-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Neoplasmsunresolved
Cancer of Lungunresolved
Cancer of the Lungunresolved
Lung Cancerunresolved
Neoplasms, Lungunresolved
Neoplasms, Pulmonaryunresolved
Pulmonary Cancerunresolved
Pulmonary Neoplasmsunresolved
Metastatic Cancer to the Lungunresolved
Interventions
Microwave ablationPROCEDURE
Sponsors & collaborators
Mayo Cliniclead sponsor
Medtronic - MITGcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02673021 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.